Many pregnant patients who are at high risk for preeclampsia aren’t receiving recommendations for prophylactic low-dose aspirin, but digital tools could facilitate better communication between patients and providers, according to a study published in JAMA Network Open.
The study used the MyHealthyPregnancy app, which was developed by Naima Health. The study’s authors were cofounders or employees...
